Next-generation sequencing (NGS) was conducted for the RAD51D genes in a 781 Chinese ovarian cancer patient cohort by the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing. The gene discussed is RAD51D; the disease is ovarian carcinoma.